Kingfa Science & Technology: Monitoring Report for Q2FY26 Shows No Deviation in Preferential Issue Utilization
Kingfa Science & Technology submitted its Q2FY26 monitoring report for the ₹500 crore preferential issue. CARE Ratings confirmed no deviation from objects, but no funds were utilized, remaining in bank deposits.
This is a routine compliance filing for the utilization of issue proceeds. It indicates a status quo with no deviation from the stated objects and no utilization of funds during the quarter, which is not expected to have a significant immediate impact on the company's stock price or operations.
The report confirms no deviation from the stated objects of the ₹500 crore preferential issue, which is a positive aspect for compliance. However, no funds have been utilized for the intended projects during the quarter, with the entire amount remaining parked in fixed deposits and bank accounts, indicating no progress on the projects during this period.
* Kingfa Science & Technology (India) Limited submitted its Monitoring Agency Report for the quarter ended September 30, 2025, to the stock exchanges. * The report, issued by CARE Ratings Limited, pertains to the utilization of proceeds from the Company's ₹500 crore preferential issue. * Key findings from the report indicate: * Nil deviation from the objects for which the funds were raised. * No utilization of the issue proceeds was recorded during the quarter ended September 30, 2025. * The entire ₹500 crore from the preferential issue remains unutilized and is currently parked in fixed deposits (₹499.90 crore) and savings/current accounts (₹0.10 crore) with Industrial and Commercial Bank of China Limited. * The planned objects of the issue, including Phase 2 Factory/Building Construction, Office Administration, R&D Building, Plant and Machinery, Land Acquisition for Expansion in South India, and General Corporate Purpose, showed no utilization during the quarter. * The estimated completion date for these projects remains June 2027. * The Monitoring Agency Report was reviewed by the Audit Committee and the Board of Directors.
What to do with a filing like this
Kingfa Science & Technology (India) Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kingfa Science & Technology (India) Limited. Read the original for the full detail.